Annual Revenue
$2.39 B
+$335.56 M+16.32%
December 31, 2023
Summary
- As of February 7, 2025, GMAB annual revenue is $2.39 billion, with the most recent change of +$335.56 million (+16.32%) on December 31, 2023.
- During the last 3 years, GMAB annual revenue has risen by +$842.59 million (+54.39%).
- GMAB annual revenue is now at all-time high.
Performance
GMAB Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$816.44 M
+$36.69 M+4.71%
September 1, 2024
Summary
- As of February 7, 2025, GMAB quarterly revenue is $816.44 million, with the most recent change of +$36.69 million (+4.71%) on September 1, 2024.
- Over the past year, GMAB quarterly revenue has increased by +$128.33 million (+18.65%).
- GMAB quarterly revenue is now at all-time high.
Performance
GMAB Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$2.89 B
+$128.33 M+4.65%
September 1, 2024
Summary
- As of February 7, 2025, GMAB TTM revenue is $2.89 billion, with the most recent change of +$128.33 million (+4.65%) on September 1, 2024.
- Over the past year, GMAB TTM revenue has increased by +$474.16 million (+19.66%).
- GMAB TTM revenue is now at all-time high.
Performance
GMAB TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
GMAB Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +16.3% | +18.6% | +19.7% |
| 3 y3 years | +54.4% | +99.8% | +36.1% |
| 5 y5 years | +399.1% | +99.8% | +36.1% |
GMAB Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +78.6% | at high | +155.4% | at high | +116.2% |
| 5 y | 5-year | at high | +197.3% | at high | +520.0% | at high | +260.7% |
| alltime | all time | at high | >+9999.0% | at high | +6057.4% | at high | +6489.1% |
Genmab A/S Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $816.44 M(+4.7%) | $2.89 B(+4.7%) |
| Jun 2024 | - | $779.75 M(+29.2%) | $2.76 B(+6.6%) |
| Mar 2024 | - | $603.46 M(-12.1%) | $2.59 B(+8.1%) |
| Dec 2023 | $2.39 B(+16.3%) | $686.83 M(-0.2%) | $2.39 B(-0.8%) |
| Sep 2023 | - | $688.11 M(+12.9%) | $2.41 B(+5.9%) |
| Jun 2023 | - | $609.32 M(+49.1%) | $2.28 B(+7.4%) |
| Mar 2023 | - | $408.70 M(-42.1%) | $2.12 B(+4.4%) |
| Dec 2022 | $2.06 B(+53.5%) | $706.18 M(+27.6%) | $2.03 B(+18.2%) |
| Sep 2022 | - | $553.31 M(+22.2%) | $1.72 B(+12.2%) |
| Jun 2022 | - | $452.67 M(+41.6%) | $1.53 B(+9.5%) |
| Mar 2022 | - | $319.65 M(-18.6%) | $1.40 B(+4.7%) |
| Dec 2021 | $1.34 B(-13.5%) | $392.83 M(+7.3%) | $1.33 B(+5.2%) |
| Sep 2021 | - | $366.23 M(+14.6%) | $1.27 B(+8.1%) |
| Jun 2021 | - | $319.59 M(+24.7%) | $1.17 B(-29.3%) |
| Mar 2021 | - | $256.29 M(-21.7%) | $1.66 B(+8.1%) |
| Dec 2020 | $1.55 B(+92.5%) | $327.42 M(+20.9%) | $1.53 B(-6.8%) |
| Sep 2020 | - | $270.83 M(-66.4%) | $1.65 B(+7.6%) |
| Jun 2020 | - | $805.00 M(+511.3%) | $1.53 B(+81.8%) |
| Mar 2020 | - | $131.69 M(-70.0%) | $842.01 M(+5.2%) |
| Dec 2019 | $804.60 M(+67.9%) | $438.95 M(+183.3%) | $800.27 M(+45.4%) |
| Sep 2019 | - | $154.93 M(+33.0%) | $550.23 M(+12.6%) |
| Jun 2019 | - | $116.45 M(+29.5%) | $488.65 M(+7.7%) |
| Mar 2019 | - | $89.95 M(-52.4%) | $453.88 M(-4.7%) |
| Dec 2018 | $479.18 M(+33.1%) | $188.92 M(+102.4%) | $476.28 M(+6.2%) |
| Sep 2018 | - | $93.35 M(+14.3%) | $448.35 M(+10.4%) |
| Jun 2018 | - | $81.67 M(-27.3%) | $406.12 M(-7.4%) |
| Mar 2018 | - | $112.35 M(-30.2%) | $438.80 M(+21.1%) |
| Dec 2017 | $359.99 M(+33.4%) | $160.99 M(+214.9%) | $362.38 M(+7.9%) |
| Sep 2017 | - | $51.12 M(-55.3%) | $335.87 M(-1.1%) |
| Jun 2017 | - | $114.35 M(+218.3%) | $339.44 M(+21.7%) |
| Mar 2017 | - | $35.93 M(-73.3%) | $278.81 M(+4.0%) |
| Dec 2016 | $269.94 M | $134.48 M(+145.9%) | $268.04 M(+23.1%) |
| Sep 2016 | - | $54.68 M(+1.8%) | $217.83 M(+6.5%) |
| Jun 2016 | - | $53.72 M(+113.5%) | $204.51 M(+15.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $25.16 M(-70.1%) | $176.54 M(+5.4%) |
| Dec 2015 | $168.57 M(+11.1%) | $84.27 M(+103.7%) | $167.55 M(+40.2%) |
| Sep 2015 | - | $41.37 M(+60.7%) | $119.49 M(-5.5%) |
| Jun 2015 | - | $25.74 M(+59.2%) | $126.41 M(+3.6%) |
| Mar 2015 | - | $16.17 M(-55.3%) | $121.98 M(-19.3%) |
| Dec 2014 | $151.68 M(+28.4%) | $36.21 M(-25.0%) | $151.17 M(-2.1%) |
| Sep 2014 | - | $48.28 M(+126.5%) | $154.38 M(+16.3%) |
| Jun 2014 | - | $21.31 M(-53.0%) | $132.69 M(-2.1%) |
| Mar 2014 | - | $45.36 M(+15.0%) | $135.57 M(+14.4%) |
| Dec 2013 | $118.16 M(+41.2%) | $39.42 M(+48.2%) | $118.49 M(+10.3%) |
| Sep 2013 | - | $26.60 M(+9.9%) | $107.42 M(+7.1%) |
| Jun 2013 | - | $24.19 M(-14.4%) | $100.28 M(+5.2%) |
| Mar 2013 | - | $28.28 M(-0.3%) | $95.37 M(+14.0%) |
| Dec 2012 | $83.69 M(+27.7%) | $28.36 M(+45.8%) | $83.67 M(+15.9%) |
| Sep 2012 | - | $19.45 M(+0.9%) | $72.16 M(+3.2%) |
| Jun 2012 | - | $19.28 M(+16.3%) | $69.94 M(+4.6%) |
| Mar 2012 | - | $16.58 M(-1.6%) | $66.85 M(+2.0%) |
| Dec 2011 | $65.56 M(-36.7%) | $16.85 M(-2.2%) | $65.52 M(+0.4%) |
| Sep 2011 | - | $17.24 M(+6.5%) | $65.27 M(-23.4%) |
| Jun 2011 | - | $16.19 M(+6.1%) | $85.24 M(-13.1%) |
| Mar 2011 | - | $15.25 M(-8.1%) | $98.06 M(-4.4%) |
| Dec 2010 | $103.63 M(-5.5%) | $16.60 M(-55.4%) | $102.61 M(-17.4%) |
| Sep 2010 | - | $37.20 M(+28.2%) | $124.29 M(+23.9%) |
| Jun 2010 | - | $29.01 M(+46.5%) | $100.35 M(+18.2%) |
| Mar 2010 | - | $19.81 M(-48.3%) | $84.92 M(-22.0%) |
| Dec 2009 | $109.68 M(-19.6%) | $38.28 M(+188.7%) | $108.92 M(+54.2%) |
| Sep 2009 | - | $13.26 M(-2.3%) | $70.64 M(+23.1%) |
| Jun 2009 | - | $13.57 M(-69.0%) | $57.38 M(+31.0%) |
| Mar 2009 | - | $43.81 M | $43.81 M |
| Dec 2008 | $136.38 M(+40.0%) | - | - |
| Dec 2007 | $97.38 M(+326.6%) | - | - |
| Dec 2006 | $22.83 M(+38.8%) | - | - |
| Dec 2005 | $16.45 M(+2298.7%) | - | - |
| Dec 2004 | $685.90 K(-93.4%) | - | - |
| Dec 2003 | $10.40 M | - | - |
FAQ
- What is Genmab A/S annual revenue?
- What is the all time high annual revenue for Genmab A/S?
- What is Genmab A/S annual revenue year-on-year change?
- What is Genmab A/S quarterly revenue?
- What is the all time high quarterly revenue for Genmab A/S?
- What is Genmab A/S quarterly revenue year-on-year change?
- What is Genmab A/S TTM revenue?
- What is the all time high TTM revenue for Genmab A/S?
- What is Genmab A/S TTM revenue year-on-year change?
What is Genmab A/S annual revenue?
The current annual revenue of GMAB is $2.39 B
What is the all time high annual revenue for Genmab A/S?
Genmab A/S all-time high annual revenue is $2.39 B
What is Genmab A/S annual revenue year-on-year change?
Over the past year, GMAB annual revenue has changed by +$335.56 M (+16.32%)
What is Genmab A/S quarterly revenue?
The current quarterly revenue of GMAB is $816.44 M
What is the all time high quarterly revenue for Genmab A/S?
Genmab A/S all-time high quarterly revenue is $816.44 M
What is Genmab A/S quarterly revenue year-on-year change?
Over the past year, GMAB quarterly revenue has changed by +$128.33 M (+18.65%)
What is Genmab A/S TTM revenue?
The current TTM revenue of GMAB is $2.89 B
What is the all time high TTM revenue for Genmab A/S?
Genmab A/S all-time high TTM revenue is $2.89 B
What is Genmab A/S TTM revenue year-on-year change?
Over the past year, GMAB TTM revenue has changed by +$474.16 M (+19.66%)